Calidi Biotherapeutics to participate in H.C. Wainwright annual global investment conference
CLDI•Conference participation
- Calidi Biotherapeutics will attend the H.C. Wainwright 28th Annual Global Investment Conference on Sept. 14-16, 2026, in New York.
- CEO Eric Poma will hold one-on-one meetings with investors during the conference dates.
